Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07228962
Recruiting
Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
Not applicable · United Kingdom · 1 site
Registry update: 5 Aug 2026
NCT07459647
Recruiting
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Phase 2 · United States · 42 sites
Registry update: 15 Oct 2026
NCT07569471
Recruiting
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in Psychosis
Not applicable · Canada · 1 site
Registry update: 6 May 2026
NCT07917442
Recruiting
Evaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in Patients With Primary Sjögren's Syndrome
Not applicable · France · 1 site
Registry update: 4 Nov 2026
NCT07466238
Recruiting
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Not applicable · China · 1 site
Registry update: 8 May 2026
NCT07391670
Recruiting
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
Phase 1 · Australia, Georgia, South Korea, Poland, Taiwan · 15 sites
Registry update: 24 Sept 2026
NCT07519850
Recruiting
The Impact of Perianal Disease on Patient's Sex Life
Not applicable · Greece · 1 site
Registry update: 9 Apr 2026
NCT07500558
Recruiting
Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for Pain Alleviation in Chronic Refractory Migraine.
Not applicable · Egypt · 2 sites
Registry update: 16 Jun 2026
NCT07295522
Recruiting
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
Phase 4 · Italy · 12 sites
Registry update: 16 Oct 2026
NCT07516522
Recruiting
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
Phase 2 · China · 1 site
Registry update: 8 Apr 2026
NCT07524114
Recruiting
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Not applicable · Canada · 1 site
Registry update: 21 Aug 2026
NCT07227233
Recruiting
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
Phase 2 · United States · 1 site
Registry update: 9 Apr 2026
NCT07478263
Recruiting
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 17 Mar 2026
NCT05752149
Recruiting
Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial
Phase 2 · Netherlands · 1 site
Registry update: 14 Sept 2026
NCT07690579
Recruiting
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Not applicable · United States · 1 site
Registry update: 8 Jul 2026
NCT06782542
Recruiting
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
Phase 2 · United States · 1 site
Registry update: 16 Apr 2026
NCT06909201
Recruiting
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
Not applicable · United States · 1 site
Registry update: 25 Aug 2026
NCT06557733
Recruiting
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Phase 2 · United States · 4 sites
Registry update: 14 Sept 2026
NCT07462377
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Phase 1 · South Korea, Taiwan, United States · 8 sites
Registry update: 14 Oct 2026
NCT07414732
Recruiting
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Not applicable · United States · 1 site
Registry update: 20 May 2026
Conflicting statuses (not updated in the registry for 5 months)

Ordered by registry start date. Freshness and sponsorship never change the order.